The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A genetic study of Wilson’s disease in the United Kingdom
Open accessAbstract
Previous studies have failed to identify mutations in the Wilson's disease gene ATP7B in a significant number of clinically diagnosed cases. This has led to concerns about genetic heterogeneity for this condition but also suggested the presence of unusual mutational mechanisms. We now present our findings in 181 patients from the United Kingdom with clinically and biochemically confirmed Wilson's disease. A total of 116 different ATP7B mutations were detected, 32 of which are novel. The overall mutation detection frequency was 98%. The likelihood of mutations in genes other than ATP7B causing a Wilson's disease phenotype is therefore very low. We report the first cases with Wilson's disease due to segmental uniparental isodisomy as well as three patients with three ATP7B mutations and three families with Wilson's disease in two consecutive generations. We determined the genetic prevalence of Wilson's disease in the United Kingdom by sequencing the entire coding region and adjacent splice sites of ATP7B in 1000 control subjects. The frequency of all single nucleotide variants with in silico evidence of pathogenicity (Class 1 variant) was 0.056 or 0.040 if only those single nucleotide variants that had previously been reported as mutations in patients with Wilson's disease were included in the analysis (Class 2 variant). The frequency of heterozygote, putative or definite disease-associated ATP7B mutations was therefore considerably higher than the previously reported occurrence of 1:90 (or 0.011) for heterozygote ATP7B mutation carriers in the general population (P < 2.2 × 10(-16) for Class 1 variants or P < 5 × 10(-11) for Class 2 variants only). Subsequent exclusion of four Class 2 variants without additional in silico evidence of pathogenicity led to a further reduction of the mutation frequency to 0.024. Using this most conservative approach, the calculated frequency of individuals predicted to carry two mutant pathogenic ATP7B alleles is 1:7026 and thus still considerably higher than the typically reported prevalence of Wilson's disease of 1:30 000 (P = 0.00093). Our study provides strong evidence for monogenic inheritance of Wilson's disease. It also has major implications for ATP7B analysis in clinical practice, namely the need to consider unusual genetic mechanisms such as uniparental disomy or the possible presence of three ATP7B mutations. The marked discrepancy between the genetic prevalence and the number of clinically diagnosed cases of Wilson's disease may be due to both reduced penetrance of ATP7B mutations and failure to diagnose patients with this eminently treatable disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S., & Schilsky, M. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60196-2 · Cited by 1,446
EASL Clinical Practice Guidelines: Wilson’s disease
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.007 · Cited by 1,243
The Wilson disease gene: spectrum of mutations and their consequences
Thomas, G. R., Forbes, J. R., Roberts, E. A., Walshe, J. M., & Cox, D. W. (1995) · Nature Genetics · doi:10.1038/ng0295-210 · Cited by 568
Dooley, J. S., & Ala, A. (2010) · Evidence‐Based Gastroenterology and Hepatology · doi:10.1002/9781444314403.ch31 · Cited by 386
Shah, A. B., Chernov, I., Zhang, H. T., Ross, B. M., Das, K., Lutsenko, S., Parano, E., Pavone, L., Evgrafov, O., Ivanova-Smolenskaya, I. A., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/514864 · Cited by 348
Mechanisms leading to uniparental disomy and their clinical consequences
Robinson, W. P. (2000) · BioEssays · Cited by 332
Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades
Taly, A. B., Meenakshi-Sundaram, S., Sinha, S., Swamy, H. S., & Arunodaya, G. R. (2007) · Medicine · doi:10.1097/md.0b013e318045a00e · Cited by 281
Ferenci, P. (2006) · Human Genetics · doi:10.1007/s00439-006-0202-5 · Cited by 271
Scheinberg, I. H. (1981) · PubMed · Cited by 257
Forbes, J. R., & Cox, D. W. (1998) · The American Journal of Human Genetics · doi:10.1086/302163 · Cited by 169
Loudianos, G., Dessi, V., Lovicu, M., Angius, A., Figus, A., Lilliu, F., De Virgiliis, S., Nurchi, A. M., Deplano, A., Moi, P., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(199910)14:4<294::aid-humu4>3.0.co;2-9 · Cited by 166
Sequence variation database for the Wilson disease copper transporter,ATP7B
Kenney, S. M., & Cox, D. W. (2007) · Human Mutation · doi:10.1002/humu.20586 · Cited by 113
Wilson’s disease—cause of mortality in 164 patients during 1992–2003 observation period
Członkowska, A., Tarnacka, B., Litwin, T., Gajda, J., & RODO, M. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0720-4 · Cited by 112
Monozygotic female twins discordant for phenotype of Wilson's disease
Członkowska, A., Gromadzka, G., & Chabik, G. (2009) · Movement Disorders · doi:10.1002/mds.22474 · Cited by 87
Lamont, P. J. (1997) · Brain · doi:10.1093/brain/120.4.673 · Cited by 83
Kegley, K. M., Sellers, M., Ferber, M. J., Johnson, M. W., Joelson, D. W., & Shrestha, R. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03071.x · Cited by 73
Pilot study of mass screening for Wilson's disease in Korea
Hahn, S. H., Lee, S., Jang, Y., Kim, S. N., Shin, H. C., Park, S. Y., Han, H. S., Yu, E. S., Yoo, H. W., Lee, J., et al. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00026-4 · Cited by 62
Inferring causality and functional significance of human coding DNA variants
Sunyaev, S. R. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds385 · Cited by 52
The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease
Lovicu, M., Dessì, V., Lepori, M. B., Zappu, A., Zancan, L., Giacchino, R., Marazzi, M. G., Iorio, R. F., Vegnente, A., Vajro, P., et al. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1807-0 · Cited by 36
Parkes, D. (1984) · BMJ · doi:10.1136/bmj.288.6425.1180 · Cited by 10
Cited by
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Moon, A. M., Singal, A. G., & Tapper, E. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.060 · Cited by 1,150
Wilson's disease and other neurological copper disorders
Bandmann, O., Weiss, K. H., & Kaler, S. G. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70190-5 · Cited by 1,036
Self-citationCzłonkowska, A., Litwin, T., Dusek, P., Ferenci, P., Lutsenko, S., Medici, V., Rybakowski, J. K., Weiss, K. H., & Schilsky, M. L. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0018-3 · Cited by 913
Abnormal liver enzymes: A review for clinicians
Kalas, M. A., Chavez, L., Leon, M., Taweesedt, P. T., & Surani, S. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i11.1688 · Cited by 332
Metadata
- Authors
- Coffey, A. J., Durkie, M., Hague, S., McLay, K., Emmerson, J., Lo, C., Klaffke, S., Joyce, C. J., Dhawan, A., Hadzic, N., Mieli-Vergani, G., Kirk, R., Elizabeth Allen, K., Nicholl, D., Wong, S., Griffiths, W., Smithson, S., Giffin, N., Taha, A., Connolly, S., Gillett, G. T., Tanner, S., Bonham, J., Sharrack, B., Palotie, A., Rattray, M., Dalton, A., & Bandmann, O.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-21
- Volume
- 136
- Issue
- 5
- Pages
- 1476-1487
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1977221972
- Cited by
- 361
- References
- 20
- FWCI
- 14.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.